Evidence map›Paper›PMID 40909330›Full record

ReviewFrontiers in physiology2025

The potential functions of ferroptosis on urinary stones: mechanisms and therapeutic implications.

Yue Ran, Yuhan Ma, Yuexin Luo, Yajun Ruan

Abstract readReview
In one paragraph

Review in Frontiers in physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yue Ran *Second Clinical Department, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Yuhan Ma *Second Clinical Department, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Yuexin LuoFirst Clinic School, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Yajun RuanSecond Clinical Department, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ferroptosis is a new type of cell death driven by iron-dependent phospholipid peroxidation, which is regulated by a variety of factors including redox homeostasis, iron metabolism, lipid metabolism, cellular metabolism, and mitochondrial function, and plays an important driving role in the development of various tissues and organ damage and diseases. Kidney stones are a common urological disease characterized by high morbidity and high recurrence rate. Currently available preventive or therapeutic treatments for kidney stones are inadequate to cope with the growing clinical demand, suffering from poor efficacy and a higher risk of postoperative complications. Accumulating experimental evidence has established mechanistic links between ferroptosis and nephrolithiasis pathogenesis, highlighting the promising potential of ferroptosis-based therapeutic strategies in kidney stone treatment. This review delves into the latest advances in ferroptosis research associated with kidney stone formation. We review the latest molecular regulatory mechanisms of ferroptosis associated with kidney stone formation from five aspects and elucidate the physiological functions and pathological roles of these pathways. In the conclusion, we critically analyze the therapeutic potential of targeting key molecular mediators within these pathways, providing strategic insights for developing novel therapeutic interventions that may overcome the limitations of conventional approaches in the future.

Indexed as

autophagyferroptosislipid peroxidationnephrolithiasisoxidative stress

Identifiers

PMID40909330
PMCPMC12405176

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.